| Primary |
| Hypertension |
52.8% |
| Type 2 Diabetes Mellitus |
7.0% |
| Pain |
4.6% |
| Product Used For Unknown Indication |
4.5% |
| Diabetes Mellitus |
4.3% |
| Blood Cholesterol Increased |
2.3% |
| Cardiac Disorder |
2.3% |
| Depression |
2.3% |
| Hypercholesterolaemia |
2.1% |
| Muscle Spasms |
2.0% |
| Rheumatoid Arthritis |
2.0% |
| Atrial Fibrillation |
1.7% |
| Anaesthesia |
1.6% |
| Angina Pectoris |
1.6% |
| Anxiety |
1.6% |
| Schizophrenia |
1.6% |
| Blood Pressure Increased |
1.5% |
| Constipation |
1.4% |
| Blood Pressure |
1.3% |
| Gastrooesophageal Reflux Disease |
1.3% |
|
| Angioedema |
10.1% |
| Renal Failure Acute |
9.8% |
| Overdose |
8.9% |
| Vomiting |
8.5% |
| Drug Hypersensitivity |
6.9% |
| Swollen Tongue |
6.7% |
| Renal Failure |
6.0% |
| Cough |
5.8% |
| Hypotension |
5.1% |
| Syncope |
4.0% |
| Hyperkalaemia |
3.8% |
| Weight Increased |
3.6% |
| White Blood Cell Count Increased |
3.4% |
| Swelling Face |
2.9% |
| Wheezing |
2.7% |
| Hypersensitivity |
2.5% |
| Urticaria |
2.5% |
| Weight Decreased |
2.5% |
| Pancreatitis |
2.2% |
| Anaphylactic Reaction |
2.0% |
|
| Secondary |
| Hypertension |
36.4% |
| Drug Use For Unknown Indication |
17.7% |
| Product Used For Unknown Indication |
7.4% |
| Pain |
6.8% |
| Type 2 Diabetes Mellitus |
4.2% |
| Cardiac Failure Congestive |
3.0% |
| Diabetes Mellitus |
3.0% |
| Hyperlipidaemia |
2.5% |
| Cardiovascular Event Prophylaxis |
2.2% |
| Depressed Mood |
2.2% |
| Atrial Fibrillation |
1.9% |
| Prophylaxis |
1.9% |
| Depression |
1.6% |
| Blood Pressure |
1.4% |
| Hypothyroidism |
1.4% |
| Arthritis |
1.3% |
| Blood Pressure Abnormal |
1.3% |
| Cardiac Failure |
1.3% |
| Coronary Artery Disease |
1.3% |
| Bladder Transitional Cell Carcinoma |
1.2% |
|
| Tubulointerstitial Nephritis |
10.2% |
| Renal Failure Acute |
8.8% |
| Urticaria |
8.2% |
| Vomiting |
6.8% |
| Hypotension |
5.4% |
| Overdose |
5.4% |
| Swollen Tongue |
5.4% |
| Transient Ischaemic Attack |
5.4% |
| Drug Toxicity |
4.1% |
| Pancreatitis |
4.1% |
| Syncope |
4.1% |
| Vision Blurred |
4.1% |
| Visual Impairment |
4.1% |
| Wheezing |
4.1% |
| Drug Hypersensitivity |
3.4% |
| Oedema Peripheral |
3.4% |
| Renal Failure |
3.4% |
| Renal Tubular Necrosis |
3.4% |
| Wrong Technique In Drug Usage Process |
3.4% |
| Blood Pressure Increased |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.7% |
| Hypertension |
16.0% |
| Drug Use For Unknown Indication |
13.9% |
| Diabetes Mellitus |
6.0% |
| Pain |
4.8% |
| Osteoporosis |
4.3% |
| Depression |
3.9% |
| Blood Cholesterol Increased |
3.2% |
| Breast Cancer |
2.9% |
| Type 2 Diabetes Mellitus |
2.8% |
| Prophylaxis |
2.6% |
| Atrial Fibrillation |
2.4% |
| Hormone Replacement Therapy |
2.4% |
| Arthritis |
2.4% |
| Multiple Myeloma |
2.0% |
| Rheumatoid Arthritis |
1.9% |
| Arthralgia |
1.8% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Blood Cholesterol |
1.7% |
| Blood Pressure |
1.6% |
|
| Weight Decreased |
13.1% |
| Myocardial Infarction |
12.6% |
| Vomiting |
11.8% |
| Weight Increased |
8.4% |
| Urinary Tract Infection |
4.9% |
| Transient Ischaemic Attack |
4.3% |
| Type 2 Diabetes Mellitus |
4.3% |
| Drug Ineffective |
4.1% |
| Nausea |
3.8% |
| Pain In Extremity |
3.7% |
| Death |
3.4% |
| Pain |
3.3% |
| Renal Failure |
3.1% |
| Renal Failure Acute |
3.1% |
| Rhabdomyolysis |
3.0% |
| Myalgia |
2.9% |
| Cerebrovascular Accident |
2.6% |
| Injury |
2.6% |
| Ventricular Tachycardia |
2.5% |
| Headache |
2.4% |
|
| Interacting |
| Product Used For Unknown Indication |
53.3% |
| Hypertension |
26.7% |
| Depression |
6.7% |
| Prophylaxis |
6.7% |
| Type 2 Diabetes Mellitus |
6.7% |
|
| Renal Failure Acute |
40.0% |
| Diarrhoea |
20.0% |
| Hypotension |
20.0% |
| Visual Acuity Reduced |
20.0% |
|
